Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
Year: 2002
Type: article
Authors: H. L??o, A. Hale, H. D??haenen
Institutions: Centre Hospitalier Sainte-Anne, St Martin's Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2022032351
